We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

High-definition Transcranial Direct Current Stimulation (HD-tDCS) Verbal Learning

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01733576
First Posted: November 27, 2012
Last Update Posted: July 23, 2015
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Melissa Pigot, The University of New South Wales
  Purpose
This project will use a new form of non-invasive brain stimulation called high-definition transcranial direct current stimulation (HD-tDCS) to facilitate verbal learning. This form of stimulation is similar to transcranial direct current stimulation (tDCS) but allows for more spatially focused stimulation. We hypothesise that HD-tDCS when applied to regions of the brain important for learning and memory will improve verbal learning and memory compared to sham HD-tDCS.

Condition Intervention Phase
Verbal Learning and Memory Device: HD-tDCS Early Phase 1

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Single (Participant)
Primary Purpose: Basic Science
Official Title: Enhancing Verbal Learning and Memory Using High-Definition Transcranial Direct Current Stimulation (HD-tDCS)

Resource links provided by NLM:


Further study details as provided by Melissa Pigot, The University of New South Wales:

Primary Outcome Measures:
  • Ray Auditory Verbal Learning Test (RAVLT)

Enrollment: 16
Primary Completion Date: March 2014 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Sham Comparator: Sham HD-tDCS Device: HD-tDCS
Active Comparator: Active HD-tDCS 1 Device: HD-tDCS
Active Comparator: Active HD-tDCS 2 Device: HD-tDCS
Active Comparator: Active HD-tDCS 3 Device: HD-tDCS

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 40 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Ages 18 - 40 years
  • Right-handed

Exclusion Criteria:

  • concurrent medication likely to affect mental performance
  • current history of drug or alcohol abuse or dependence
  • any psychiatric or neurological disorder, recent head injury, or history of seizure or stroke.
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01733576


Locations
Australia, New South Wales
Black Dog Institute
Sydney, New South Wales, Australia, 2031
Sponsors and Collaborators
The University of New South Wales
  More Information

Responsible Party: Melissa Pigot, Research Assistant, The University of New South Wales
ClinicalTrials.gov Identifier: NCT01733576     History of Changes
Other Study ID Numbers: CB64
First Submitted: November 26, 2012
First Posted: November 27, 2012
Last Update Posted: July 23, 2015
Last Verified: July 2015